Login to Your Account



Other News To Note


Thursday, July 18, 2013
Biospecifics Technologies Corp., of Lynbrook, N.Y., said its partner Auxilium Pharmaceuticals Inc., of Malvern, Pa., has entered a collaboration with Swedish Orphan Biovitrum AB (Sobi), of Stockholm, for the long-term development, supply and commercialization of Xiapex (collagenase clostridium histolyticum) for the treatment of Dupuytren's contracture.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription